Voloridge Investment Management
MDGL icon

Voloridge Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Voloridge Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-59,189
Closed -$14.3M – 1480
2023
Q1 		$14.3M Buy
59,189
+54,232
+1,094% +$14.8M 0.07% 363
2022
Q4 		$1.44M Buy
+4,957
New +$485K 0.01% 1050
2020
Q3 		– Sell
-20,174
Closed -$2.29M – 1398
2020
Q2 		$2.29M Buy
+20,174
New +$1.98M 0.03% 578
2019
Q1 		– Sell
-16,664
Closed -$1.88M – 1016
2018
Q4 		$1.88M Buy
+16,664
New +$2.58M 0.09% 206

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return